Table 2 Correlation between serum CEA or CA15-3 levels at baseline and first metastatic sites
Metastatic sites | CEA high (n = 191) | CEA lowa (n = 885) | p value | CA15-3 high (n = 314) | CA15-3 lowb (n = 762) | p value |
|---|---|---|---|---|---|---|
No metastasis | ||||||
| Â | 154 (16.4)c | 787 (83.6) | Â | 249 (36.0) | 692 (64.0) | Â |
Visceral metastasis | ||||||
|  | 19 (36.5) | 33 (63.5) | 0.0006 | 31 (59.6) | 21 (40.4) | < 0.0001 |
Boned | ||||||
|  | 7 (25.0) | 21 (75.0) | 0.298 | 14 (50.0) | 14 (50.0) | < 0.0001 |
Locoreginal and soft tissued | ||||||
| Â | 11 (20.0) | 44 (80.0) | 0.458 | 20 (36.4) | 35 (63.4) | 0.119 |